J. Rheumatol. 2020 Feb 01
Feasibility and face validity of outcome measures for use in future studies of Polymyalgia Rheumatica (PMR): An OMERACT Study.
Yates M, Owen CE, Muller S, Graham K, Neill L, Twohig H, Boers M, Pujades-Rodriguez M, Goodman S, Cheah J, Dejaco C, Mukhtyar C, Nielsen BD, Robson J, Simon LS, Shea B, Mackie SL, Hill CL
The aim of this study was to survey participants with PMR to evaluate the face validity, acceptability and domain match of proposed candidate outcome ...
Read More
Source: PubMed
J. Rheumatol. 2020 Feb 01
Outcomes and safety of TNF inhibitors in reactive arthritis: A nationwide experience from Iceland.
Thorsteinsson B, Geirsson AJ, Krogh NS, Gudbjornsson B
Reactive arthritis (ReA) is a spondyloarthritis triggered by a bacterial infection. In cases where nonsteroidal anti-inflammatory drugs and convention ...
Read More
Source: PubMed
J. Rheumatol. 2020 Feb 01
Expert consensus on a set of outcomes to assess the effectiveness of biologic treatment in psoriatic arthritis: the MERECES study.
Cañete JD, Nolla JM, Queiro R, Rodríguez MJ, Ruiz M, Lizán L
To reach a consensus on the instruments to be used in clinical practice to evaluate the effectiveness of biological disease-modifying antirheumatic dr ...
Read More
Source: PubMed
Biomed. Pharmacother.
Total glucosides of paeony decreases apoptosis of hepatocytes and inhibits maturation of dendritic cells in autoimmune hepatitis.
Shen M, Men R, Fan X, Wang T, Huang C, Wang H, Ye T, Luo X, Yang L
Total glucosides of paeony (TGP), an active mixture extracted from paeony root, has anti-inflammatory and immunoregulatory effects and is widely used ...
Read More
Source: PubMed
Clin. Rheumatol. 2020 Jan 30
Plasma gelsolin levels in patients with psoriatic arthritis: a possible novel marker.
Esawy MM, Makram WK, Albalat W, Shabana MA
Psoriatic arthritis (PsA) is an inflammatory disorder affecting the joints of psoriatic patients. Gelsolin regulated the actin assembly and disassembl ...
Read More
Source: PubMed
